4//SEC Filing
Nexvet Biopharma plc 4
Accession 0001572426-16-000158
CIK 0001618561operating
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:43 PM ET
Size
6.7 KB
Accession
0001572426-16-000158
Insider Transaction Report
Form 4
Lismore Damian T.
Chief Financial Officer
Transactions
- Purchase
Ordinary Shares
2016-02-18$3.22/sh+5,000$16,100→ 18,724 total(indirect: Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C>)
Holdings
- 14,160(indirect: By Spouse)
Ordinary Shares
- 16,000
Ordinary Shares
Footnotes (2)
- [F1]Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.29, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001618561
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:43 PM ET
- Size
- 6.7 KB